Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
1982; Lippincott Williams & Wilkins; Volume: 65; Issue: 4 Linguagem: Inglês
10.1161/01.cir.65.4.671
ISSN1524-4539
AutoresJean‐Lucien Rouleau, Kanu Chatterjee, William Benge, William W. Parmley, B Hiramatsu,
Tópico(s)Cardiovascular Function and Risk Factors
ResumoHomeCirculationVol. 65, No. 4Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBAlterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. J L Rouleau, K Chatterjee, W Benge, W W Parmley and B Hiramatsu J L RouleauJ L Rouleau , K ChatterjeeK Chatterjee , W BengeW Benge , W W ParmleyW W Parmley and B HiramatsuB Hiramatsu Originally published1 Apr 1982https://doi.org/10.1161/01.CIR.65.4.671Circulation. 1982;65:671–678 eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Gupta D, Georgiopoulou V, Kalogeropoulos A, Marti C, Yancy C, Gheorghiade M, Fonarow G, Konstam M and Butler J (2013) Nitrate Therapy for Heart Failure, JACC: Heart Failure, 10.1016/j.jchf.2013.03.003, 1:3, (183-191), Online publication date: 1-Jun-2013. Hauptman P and Swedberg K (2009) Management of Overt Heart Failure Evidence‐Based Cardiology, 10.1002/9781444309768.ch47, (756-783), Online publication date: 13-Nov-2009. Chatterjee K (2009) Coronary Hemodynamics in Heart Failure and Effects of Therapeutic Interventions, Journal of Cardiac Failure, 10.1016/j.cardfail.2009.01.001, 15:2, (116-123), Online publication date: 1-Mar-2009. Lipinski M and Vetrovec G (2006) Medical Treatment of Patients with Heart Failure or Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention, American Journal of Cardiovascular Drugs, 10.2165/00129784-200606050-00004, 6:5, (313-325), . Andersson B and Swedberg K (2002) Management of Overt Heart Failure Evidence‐based Cardiology, 10.1002/9780470986882.ch46, (659-680), Online publication date: 20-Nov-2002. Chatterjee K (2002) Dilated Cardiomyopathy and Coronary Arteries Pan Vascular Medicine, 10.1007/978-3-642-56225-9_62, (987-994), . Ertl G and Hu K (2001) Anti-Ischemic Potential of Drugs related to the Renin-Angiotensin System, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200109011-00003, 37, (S11-S20), Online publication date: 1-Sep-2001. Konermann M, Altmann C, Laschewski F, Josephs W, Odenthal H, Horstmann E and Sanner B (2009) Influence of tissue affinity of angiotensin‐converting enzyme inhibitors on left ventricular remodeling after myocardial infarction, Clinical Cardiology, 10.1002/clc.4960210409, 21:4, (277-285), Online publication date: 1-Apr-1998. Hitzenberger G (1998) ACE-Hemmer Herzerkrankungen und Interventions-möglichkeiten, 10.1007/978-3-642-80404-5_18, (331-341), . Takeda H, Haneda T and Kikuchi K (1997) Protective Effect of the Angiotensin-Converting Enzyme Inhibitor Captopril on Postischemic Myocardial Damage in Perfused Rat Heart, Japanese Circulation Journal, 10.1253/jcj.61.687, 61:8, (687-694), . Ferrari R (1997) Angiotensin converting enzyme inhibitor–calcium antagonist combination, Journal of Hypertension, 10.1097/00004872-199715022-00011, 15, (S109-S117), . Hayashida W, Donckier J, Van Mechelen H, Charlier A and Pouleur H (1997) Diastolic properties in canine hypertensive left ventricular hypertrophy: Effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade, Cardiovascular Research, 10.1016/S0008-6363(96)00194-0, 33:1, (54-62), Online publication date: 1-Jan-1997., Online publication date: 1-Jan-1997. Ertl G, Hu K, Bauer W and Bauer B (1996) The renin-angiotensin system and coronary vasomotion, Heart, 10.1136/hrt.76.3_Suppl_3.45, 76:3 Suppl 3, (45-52), Online publication date: 1-Nov-1996. Ferrari R, Ceconi C, Curello S, Pepi P, Mazzoletti A and Visioli O (1996) Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease, Cardiovascular Drugs and Therapy, 10.1007/BF00052511, 10:S2, (639-647), Online publication date: 1-Nov-1996. Greenwald L and Becker R (1994) Expanding the paradigm of the renin-angiotensin system and angiotensin-converting enzyme inhibitors, American Heart Journal, 10.1016/0002-8703(94)90600-9, 128:5, (997-1009), Online publication date: 1-Nov-1994. Lonn E, Yusuf S, Jha P, Montague T, Teo K, Benedict C and Pitt B (1994) Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection., Circulation, 90:4, (2056-2069), Online publication date: 1-Oct-1994. Ambrosioni E, Borghi C and Magnani B (1994) Survival of myocardial infarction long-term evaluation (SMILE) study: Rationale, design, organization, and outcome definitions, Controlled Clinical Trials, 10.1016/0197-2456(94)90057-4, 15:3, (201-210), Online publication date: 1-Jun-1994. Haas G and Leier C (1994) Vasodilators Congestive Heart Failure, 10.1007/978-1-4613-8315-4_24, (400-453), . Chatterjee K and Collins P (1993) Ischaemic heart failure: is prevention in sight?, Heart, 10.1136/hrt.70.1.5, 70:1, (5-7), Online publication date: 1-Jul-1993. Vogt M, Motz W and Strauer B (1993) ACE-Hemmer bei koronarer Herzkrankheit Angiotensin und Herz, 10.1007/978-3-662-11145-1_4, (49-70), . Krajcar M and Heusch G (1993) Lokale und neurohumorale Kontrolle der Koronardurchblutung Angiotensin und Herz, 10.1007/978-3-662-11145-1_3, (29-47), . Vogt M, Motz W and Strauer B (1993) ACE-inhibitors in coronary artery disease? Angiotensin and the Heart, 10.1007/978-3-642-72497-8_4, (43-64), . Krajcar M and Heusch G (1993) Local and neurohumoral control of coronary blood flow Angiotensin and the Heart, 10.1007/978-3-642-72497-8_3, (25-42), . NORDREHAUG J, OMSJØ I and VOLLSET S (2009) A 3‐month double‐blind cross‐over study of the effect of benazepril and hydrochlorothiazide on functional class in symptomatic mild heart failure, Journal of Internal Medicine, 10.1111/j.1365-2796.1992.tb01244.x, 231:6, (589-594), Online publication date: 1-Jun-1992. Wisenbaugh T, Essop R, Rothlisberger C and Sareli P (1992) Effects of a single oral dose of captopril on left ventricular performance in severe mitral regurgitation, The American Journal of Cardiology, 10.1016/0002-9149(92)90232-N, 69:4, (348-353), Online publication date: 1-Feb-1992. Th�rmann P and Rietbrock N (1992) Current concepts: converting enzyme inhibitors in coronary artery disease, The Clinical Investigator, 10.1007/BF00422945, 70:1, (70-76), Online publication date: 1-Jan-1992. Wisenbaugh T, Essop R and Sareli P (1991) Short-term vasodilator effect of captopril in patients with severe mitral regurgitation is parasympathetically mediated., Circulation, 84:5, (2049-2053), Online publication date: 1-Nov-1991. Akhras F and Jackson G (1991) The role of captopril as single therapy in hypertension and angina pectoris, International Journal of Cardiology, 10.1016/0167-5273(91)90356-T, 33:2, (259-266), Online publication date: 1-Nov-1991. Kiowski W, Zuber M, Elsasser S, Erne P, Pfisterer M and Burkart F (1991) Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure, American Heart Journal, 10.1016/0002-8703(91)90581-2, 122:5, (1382-1388), Online publication date: 1-Nov-1991. Packer M and Kukin M (1991) Management of patients with heart failure and angina: Do coexistent diseases alter the response to cardiovascular drugs?, Journal of the American College of Cardiology, 10.1016/S0735-1097(10)80193-7, 17:3, (740-742), Online publication date: 1-Mar-1991. Cleland J, Henderson E, McLenachan J, Findlay I and Dargie H (1991) Effect of Captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure, Journal of the American College of Cardiology, 10.1016/S0735-1097(10)80192-5, 17:3, (733-739), Online publication date: 1-Mar-1991. Munger M, Gardner S and Jarvis R (2016) Endocrinologic Warfare: The Role of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure, Journal of Pharmacy Practice, 10.1177/089719009000300506, 3:5, (318-331), Online publication date: 1-Oct-1990. Linder C and Heusch G (1990) ACE inhibitors for the treatment of myocardial ischemia?, Cardiovascular Drugs and Therapy, 10.1007/BF02018265, 4:5, (1375-1384), Online publication date: 1-Sep-1990. Massie B (1990) All patients with left ventricular systolic dysfunction should be treated with an angiotensin-converting enzyme inhibitor: A protagonist's viewpoint, The American Journal of Cardiology, 10.1016/0002-9149(90)90701-2, 66:4, (439-443), Online publication date: 1-Aug-1990. Ikram H, Low C, Shirlaw T, Webb C, Richards A and Crozier I (1990) Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris, The American Journal of Cardiology, 10.1016/0002-9149(90)90581-K, 66:2, (164-167), Online publication date: 1-Jul-1990. Raia J, Barone J, Byerly W and Lacy C (2016) Angiotensin-Converting Enzyme Inhibitors: A Comparative Review, DICP, 10.1177/106002809002400512, 24:5, (506-525), Online publication date: 1-May-1990. Lorimer A, MacFarlane P, Pringle S, Barbour M, Fox Y and Lawrie T (1990) The effects of felodipine in angina pectoris, European Journal of Clinical Pharmacology, 10.1007/BF02336676, 38:5, (415-419), Online publication date: 1-May-1990. Rouleau J, Juneau C and de Champlain J (1989) The use of angiotensin-converting enzyme inhibitors in congestive heart failure, Cardiovascular Drugs and Therapy, 10.1007/BF01869576, 3:6, (883-890), Online publication date: 1-Nov-1989. Hasenfuss G, Holubarsch C, Heiss H and Just H (1989) Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy, American Heart Journal, 10.1016/0002-8703(89)90266-4, 118:3, (512-519), Online publication date: 1-Sep-1989. Simon J, Gibbs R, Crean P, Mockus L, Wright C, Sutton G and Fox K (1989) The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina., Heart, 10.1136/hrt.62.2.112, 62:2, (112-117), Online publication date: 1-Aug-1989. Jessup M (1989) Angiotensin-converting enzymeI inhibitors: Are there significant clinical differences?, Journal of the American College of Cardiology, 10.1016/0735-1097(89)90295-7, 13:6, (1248-1250), Online publication date: 1-May-1989. Remme W (1989) Vasodilator therapy without converting-enzyme inhibition in congestive heart failure—Usefulness and limitations, Cardiovascular Drugs and Therapy, 10.1007/BF01858109, 3:3, (375-396), Online publication date: 1-May-1989. McMurray J, Lang C, Maclean D, McDevitt D and Struthers A (2016) A Survey of Current Use of Angiotensin-Converting-Enzyme Inhibitors by Scottish Physicians in the Treatment of Chronic Cardiac Failure, Scottish Medical Journal, 10.1177/003693308903400204, 34:2, (425-427), Online publication date: 1-Apr-1989. Borek M, Charlap S and Frishman W (1989) Angiotensin-converting Enzyme Inhibitors in Heart Failure, Medical Clinics of North America, 10.1016/S0025-7125(16)30675-7, 73:2, (315-338), Online publication date: 1-Mar-1989. Dzau V and Creager M (1989) Progress in Angiotensin-Converting Enzyme Inhibition in Heart Failure: Rationale, Mechanisms, and Clinical Responses, Cardiology Clinics, 10.1016/S0733-8651(18)30461-2, 7:1, (119-130), Online publication date: 1-Feb-1989. Chatterjee K (1989) Digitalis and Non-ACE Inhibitor Vasodilators in Heart Failure, Cardiology Clinics, 10.1016/S0733-8651(18)30460-0, 7:1, (99-118), Online publication date: 1-Feb-1989. Chatterjee K (1989) Hemodynamic studies-their uses and limitations, The American Journal of Cardiology, 10.1016/0002-9149(89)90409-8, 63:8, (D3-D7), Online publication date: 1-Feb-1989. Westheim A, Bae E, Christensen C, Fønstelien E, Grendahl H and Muller O (2008) Changes in coronary haemodynamics and myocardial metabolism at rest and during exercise after a cardiotonic drug (prenalterol) in patients with coronary artery disease, Clinical Physiology, 10.1111/j.1475-097X.1988.tb00212.x, 8:5, (463-474), Online publication date: 1-Oct-1988. Firth B (1988) Southwestern Internal Medicine Conference: The Multifacetted Role of Angiotensin Converting Enzyme Inhibitors in Congestive Heart Failure, The American Journal of the Medical Sciences, 10.1016/S0002-9629(15)40869-9, 296:4, (275-288), Online publication date: 1-Oct-1988. Kiowski W and Burkart F (1988) Effects of vasodilators on the coronary circulation in congestive heart failure, The American Journal of Cardiology, 10.1016/S0002-9149(88)80021-3, 62:8, (99E-103E), Online publication date: 1-Sep-1988. Faxon D (1988) ACE inhibition for the failing heart: Experience with captopril, American Heart Journal, 10.1016/0002-8703(88)90081-6, 115:5, (1085-1093), Online publication date: 1-May-1988. Massie B (1988) New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure, The American Journal of Medicine, 10.1016/S0002-9343(88)80166-9, 84, (36-46), Online publication date: 1-Apr-1988. Massie B (1988) New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure, The American Journal of Medicine, 10.1016/0002-9343(88)90468-8, 84:4, (36-46), Online publication date: 1-Apr-1988. Rotmensch H, Vlasses P and Ferguson R (1988) Angiotensin-Converting Enzyme Inhibitors, Medical Clinics of North America, 10.1016/S0025-7125(16)30776-3, 72:2, (399-425), Online publication date: 1-Mar-1988. Magnani B (1988) Converting enzyme inhibition and heart failure, The American Journal of Medicine, 10.1016/0002-9343(88)90210-0, 84:3, (87-91), Online publication date: 1-Mar-1988. Foult J, Tavolaro O, Antony I and Nitenberg A (1988) Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique., Circulation, 77:2, (337-344), Online publication date: 1-Feb-1988. Chatterjee K, De Marco T and Rouleau J (1988) Vasodilator therapy in chronic congestive heart failure, The American Journal of Cardiology, 10.1016/S0002-9149(88)80085-7, 62:2, (46A-54A), . Rietbrock N and Kubin S (1988) Vasodilatatoren bei schwerer Herzinsuffizienz Herz- und Kreislauferkrankungen, 10.1007/978-3-663-14091-7_4, (65-79), . Schneeweiss A and Schettler G (1988) Captopril Cardiovascular Drug Therapy in the Elderly, 10.1007/978-1-4613-2063-0_9, (56-69), . Installé E, Gonzalez M, Jacquemart J, Collard P, Roulette F, Pourbaix S and Tremouroux J (1987) Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure, The American Journal of Cardiology, 10.1016/0002-9149(87)90525-X, 60:5, (46-52), Online publication date: 1-Aug-1987. Barjon J, Rouleau J, Bichet D, Juneau C and De Champlain J (1987) Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure, Journal of the American College of Cardiology, 10.1016/S0735-1097(87)80057-8, 9:3, (622-630), Online publication date: 1-Mar-1987. Chatterjee K and Opie L (1987) Angiotensin inhibitors and other vasodilators with special reference to congestive heart failure, Cardiovascular Drugs and Therapy, 10.1007/BF02125827, 1:1, (1-8), Online publication date: 1-Jan-1987. Hamer J (1987) Vasodilator therapy in congestive heart failure Drugs for Heart Disease, 10.1007/978-1-4899-3294-5_9, (275-298), . Schneeweiss A and Schettler G (1987) Hydralazine Cardiovascular Drug Therapy in the Elderly, 10.1007/978-1-4613-2063-0_20, (181-190), . Daly P, Rouleau J, Cousineau D, Burgess J and Chatterjee K (1986) Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure., Heart, 10.1136/hrt.56.2.152, 56:2, (152-157), Online publication date: 1-Aug-1986. Ruggie N (1986) Congestive Heart Failure, Medical Clinics of North America, 10.1016/S0025-7125(16)30927-0, 70:4, (829-851), Online publication date: 1-Jul-1986. Wahr D and Chatterjee K (1986) Hemodynamic Consequences of Myocardial Infarction and the Role of Vasodilators in Acute and Chronic Management The Pathophysiology and Pharmacotherapy of Myocardial Infarction, 10.1016/B978-0-12-238045-7.50008-X, (39-84), . Parmley W and Chatterjee K (1986) Congestive heart failure and arrhythmias: An overview, The American Journal of Cardiology, 10.1016/0002-9149(86)90996-3, 57:3, (B34-B37), Online publication date: 1-Jan-1986. Rutishauser W (1986) Hydralazin bei chronischer Herzinsuffizienz. Pro und contra Vasoaktive Substanzen bei Herzinsuffizienz, 10.1007/978-3-642-71486-3_11, (76-80), . Bussmann W (1986) Converting Enzyme Inhibition: Therapy for Chronic Heart Failure Acute and Chronic Heart Failure, 10.1007/978-3-642-61627-3_21, (252-279), . Francis G and Cohn J (1986) Afterload Reduction Topics in Clinical Pharmacology and Therapeutics, 10.1007/978-1-4612-4864-4_6, (135-150), . Packer M, Medina N, Yushak M and Lee W (1985) Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: Results of a randomized crossover study, American Heart Journal, 10.1016/0002-8703(85)90354-0, 109:6, (1293-1299), Online publication date: 1-Jun-1985. Emanuelsson H and Holmberg S (2009) No adverse effects from high doses of felodipine to patients with coronary heart disease, Clinical Cardiology, 10.1002/clc.4960080605, 8:6, (329-336), Online publication date: 1-Jun-1985. Monrad E, Baim D, Smith H, Lanoue A, Brauwald E and Grossman W (1985) Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure., Circulation, 71:5, (972-979), Online publication date: 1-May-1985. Chatterjee K (1985) Recent Advances in the Management of Chronic Heart Failure, Primary Care: Clinics in Office Practice, 10.1016/S0095-4543(21)01244-6, 12:1, (117-142), Online publication date: 1-Mar-1985. Drexler H, Truog A, Just H and Zelis R (1985) Die Beeinflussung der Organperfusion durch Kalziumblocker und Converting-Enzyminhibitor an der herzinsuffizienten, wachen RatteEffects of calcium-blockade and converting-enzyme inhibition on regional blood flow in a conscious rat model of heart failure, Klinische Wochenschrift, 10.1007/BF01731472, 63:6, (262-267), Online publication date: 1-Mar-1985. Daly P, Mettauer B, Rouleau J, Cousineau D and Burgess J (1985) Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect., Circulation, 71:2, (317-325), Online publication date: 1-Feb-1985. Francis G and Cohn J (1985) Vasoactive Drugs and the Failing Ventricle The Ventricle, 10.1007/978-1-4613-2599-4_16, (315-336), . Martin J, Likoff M, Janicki J, Laskey W, Hirshfeld J and Weber K (1984) Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure, Journal of the American College of Cardiology, 10.1016/S0735-1097(84)80046-7, 4:5, (875-883), Online publication date: 1-Nov-1984. Ferguson R, Vlasses P and Rotmensch H (1984) Clinical applications of angiotensin-converting enzyme inhibitors, The American Journal of Medicine, 10.1016/0002-9343(84)90367-X, 77:4, (690-698), Online publication date: 1-Oct-1984. Konstam M, Salem D, Isner J, Zile M, Kahn P, Bonin J, Cohen S and Levine H (1984) Vasodilator effect on right ventricular function in congestive heart failure and pulmonary hypertension: End-systolic pressure-volume relation, The American Journal of Cardiology, 10.1016/0002-9149(84)90317-5, 54:1, (132-136), Online publication date: 1-Jul-1984. Packer M (1984) Conceptual dilemmas in the classification of vasodilator drugs for severe chronic heart failure, The American Journal of Medicine, 10.1016/0002-9343(84)91037-4, 76:6, (3-13), Online publication date: 1-Jun-1984. Faxon D, Creager M, Halperin J, Bernard D and Ryan T (1984) Redistribution of regional blood flow following angiotensin-converting enzyme inhibition, The American Journal of Medicine, 10.1016/0002-9343(84)90895-7, 76:5, (104-110), Online publication date: 1-May-1984. Elkayam U, Weber L, Torkan B, Mckay C and Rahimtoola S (1984) Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure, The American Journal of Cardiology, 10.1016/0002-9149(84)90087-0, 53:9, (1321-1325), Online publication date: 1-May-1984. Sjögren A (2009) Treatment of congestive heart failure, Acta Pharmacologica et Toxicologica, 10.1111/j.1600-0773.1984.tb03640.x, 54:s1, (93-101), Online publication date: 1-Apr-1984. Weber K, Likoff M, Janicki J and Andrews V (1984) Advances in the Evaluation and Management of Chronic Cardiac Failure, Chest, 10.1378/chest.85.2.253, 85:2, (253-259), Online publication date: 1-Feb-1984. Bussmann W (1984) Der Einsatz von Vasodilatatoren bei chronischer Herzinsuffizienz Herzinsuffizienz, 10.1007/978-3-642-82183-7_16, (657-718), . Mattioli G, Zennaro R, Benassi A, Modena M and Luppi G (1984) Coronary Blood Flow Modifications After Administration of Captopril The Coronary Sinus, 10.1007/978-3-642-54127-8_31, (221-226), . Ports T, Chatterjee K, Wilkinson P, Avakian D and Parmley W (1983) Trimazosin in chronic congestive heart failure: Improved left ventricular function at rest and during exercise, American Heart Journal, 10.1016/0002-8703(83)90649-X, 106:5, (1036-1042), Online publication date: 1-Nov-1983. Laskey W, Reichek N, Sutton M, Untereker W and Hirshfeld J (1983) Myocardial oxygen consumption in left ventricular hypertrophy and its relation to left ventricular mechanics, The American Journal of Cardiology, 10.1016/0002-9149(83)90427-7, 52:7, (852-858), Online publication date: 1-Oct-1983. Ferlinz J and Citron P (1983) Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure, The American Journal of Cardiology, 10.1016/0002-9149(83)90309-0, 51:8, (1339-1345), Online publication date: 1-May-1983. Rousseau M, Pouleur H and Vincent M (1983) Effects of a cardioselective beta1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction, The American Journal of Cardiology, 10.1016/0002-9149(83)90297-7, 51:8, (1267-1274), Online publication date: 1-May-1983. Schanzenb�cher P and Liebau G (1983) Effect of captopril on left ventricular dynamics in patients with chronic left ventricular volume overload, Klinische Wochenschrift, 10.1007/BF01485025, 61:7, (343-347), Online publication date: 1-Apr-1983. Iseri L and Benvenuti D (1983) Pathogenesis and management of congestive heart failure—revisited, American Heart Journal, 10.1016/0002-8703(83)90547-1, 105:2, (346-350), Online publication date: 1-Feb-1983. Chatterjee K and Parmley W (1983) Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure, Journal of the American College of Cardiology, 10.1016/S0735-1097(83)80018-7, 1:1, (133-153), Online publication date: 1-Jan-1983. Swan H and Ganz W (1983) Hemodynamic measurements in clinical practice: A decade in review, Journal of the American College of Cardiology, 10.1016/S0735-1097(83)80015-1, 1:1, (103-113), Online publication date: 1-Jan-1983. Powers E, Bannerman K, Stone J, Reison D, Escala E, Alan K, Weiss M, Sciacca R and Cannon P (1982) The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure, American Heart Journal, 10.1016/0002-8703(82)90052-7, 104:5, (1203-1210), Online publication date: 1-Nov-1982. Chatterjee K, Rouleau J and Parmley W (1982) Captopril in congestive heart failure: Improved left ventricular function with decreased metabolic cost, American Heart Journal, 10.1016/0002-8703(82)90042-4, 104:5, (1137-1146), Online publication date: 1-Nov-1982. Steingo L, Pocock W, Flax H, Stein M and Barlow J (2012) Long‐term captopril therapy in severe refractory congestive heart failure., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1982.tb02078.x, 14:S2, Online publication date: 1-Apr-1982. Weber K (1982) New hope for the failing heart, The American Journal of Medicine, 10.1016/0002-9343(82)90478-8, 72:4, (665-671), Online publication date: 1-Apr-1982. April 1, 1982Vol 65, Issue 4 Advertisement Article InformationMetrics Copyright © 1982 by American Heart Associationhttps://doi.org/10.1161/01.CIR.65.4.671 Originally publishedApril 1, 1982 PDF download Advertisement
Referência(s)